A mitochondrial variant percentage describes a sampled specimen. Researchers must connect tissue, assay sensitivity and variant evidence before drawing conclusions about disease.
CYP21A2 illustrates how similar DNA sequences and complex gene structures challenge genetic analysis—and why research methods need locus-specific validation.